208 related articles for article (PubMed ID: 2256110)
1. Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrrole.
Reindel JF; Ganey PE; Wagner JG; Slocombe RF; Roth RA
Toxicol Appl Pharmacol; 1990 Nov; 106(2):179-200. PubMed ID: 2256110
[TBL] [Abstract][Full Text] [Related]
2. Early indications of monocrotaline pyrrole-induced lung injury in rats.
Schultze AE; Wagner JG; White SM; Roth RA
Toxicol Appl Pharmacol; 1991 Jun; 109(1):41-50. PubMed ID: 2038748
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of procoagulant activity in the peripheral blood of rats treated with monocrotaline pyrrole.
Schultze AE; Wagner JG; Roth RA
Toxicol Appl Pharmacol; 1991 Jul; 109(3):421-31. PubMed ID: 1830177
[TBL] [Abstract][Full Text] [Related]
4. Effects of altered platelet number on pulmonary hypertension and platelet sequestration in monocrotaline pyrrole-treated rats.
White SM; Wagner JG; Roth RA
Toxicol Appl Pharmacol; 1989 Jun; 99(2):302-13. PubMed ID: 2734793
[TBL] [Abstract][Full Text] [Related]
5. The effect of immunosuppressants and adoptive transfer in monocrotaline pyrrole pneumotoxicity.
Bruner LH; Bull RW; Roth RA
Toxicol Appl Pharmacol; 1987 Oct; 91(1):1-12. PubMed ID: 3672514
[TBL] [Abstract][Full Text] [Related]
6. Injury to the isolated, perfused lung by exposure in vitro to monocrotaline pyrrole.
Hilliker KS; Roth RA
Exp Lung Res; 1985; 8(4):201-12. PubMed ID: 4043006
[TBL] [Abstract][Full Text] [Related]
7. Cellular fibronectin and von Willebrand factor concentrations in plasma of rats treated with monocrotaline pyrrole.
Schultze AE; Emeis JJ; Roth RA
Biochem Pharmacol; 1996 Jan; 51(2):187-91. PubMed ID: 8615888
[TBL] [Abstract][Full Text] [Related]
8. Lactate dehydrogenase activity and isozyme patterns in tissues and bronchoalveolar lavage fluid from rats treated with monocrotaline pyrrole.
Schultze AE; Gunaga KP; Wagner JG; Hoorn CM; Moorehead WR; Roth RA
Toxicol Appl Pharmacol; 1994 Jun; 126(2):301-10. PubMed ID: 8209383
[TBL] [Abstract][Full Text] [Related]
9. Effects of thrombocytopenia on monocrotaline pyrrole-induced pulmonary hypertension.
Hilliker KS; Bell TG; Lorimer D; Roth RA
Am J Physiol; 1984 Jun; 246(6 Pt 2):H747-53. PubMed ID: 6742140
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary hypertension due to monocrotaline pyrrole is reduced by moderate thrombocytopenia.
Ganey PE; Sprugel KH; White SM; Wagner JG; Roth RA
Am J Physiol; 1988 Nov; 255(5 Pt 2):H1165-72. PubMed ID: 3189578
[TBL] [Abstract][Full Text] [Related]
11. The effect of dietary restriction and altered sodium intake on the cardiopulmonary toxicity of monocrotaline pyrrole.
Ganey PE; Fink GD; Roth RA
Toxicol Appl Pharmacol; 1985 Mar; 78(1):55-62. PubMed ID: 2930913
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary platelet sequestration is increased following monocrotaline pyrrole treatment of rats.
White SM; Roth RA
Toxicol Appl Pharmacol; 1988 Dec; 96(3):465-75. PubMed ID: 2974653
[TBL] [Abstract][Full Text] [Related]
13. Hypertrophy and prolonged DNA synthesis in smooth muscle cells characterize pulmonary arterial wall thickening after monocrotaline pyrrole administration to rats.
Lappin PB; Roth RA
Toxicol Pathol; 1997; 25(4):372-80. PubMed ID: 9280120
[TBL] [Abstract][Full Text] [Related]
14. Complement is not involved in monocrotaline pyrrole-induced pulmonary injury.
Bruner LH; Johnson KJ; Till GO; Roth RA
Am J Physiol; 1988 Feb; 254(2 Pt 2):H258-64. PubMed ID: 3344816
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary hypertension and ECG changes from monocrotaline pyrrole in the rat.
Bruner LH; Hilliker KS; Roth RA
Am J Physiol; 1983 Aug; 245(2):H300-6. PubMed ID: 6224428
[TBL] [Abstract][Full Text] [Related]
16. Lung vascular injury from monocrotaline pyrrole, a putative hepatic metabolite.
Roth RA; Reindel JF
Adv Exp Med Biol; 1991; 283():477-87. PubMed ID: 1906225
[TBL] [Abstract][Full Text] [Related]
17. Lack of effect of deferoxamine, dimethyl sulfoxide, and catalase on monocrotaline pyrrole pulmonary injury.
Bruner LH; Johnson K; Carpenter LJ; Roth RA
J Toxicol Environ Health; 1987; 21(1-2):205-17. PubMed ID: 3573071
[TBL] [Abstract][Full Text] [Related]
18. Alteration of monocrotaline pyrrole-induced cardiopulmonary effects in rats by hydrallazine, dexamethasone or sulphinpyrazone.
Hilliker KS; Roth RA
Br J Pharmacol; 1984 Jun; 82(2):375-80. PubMed ID: 6234044
[TBL] [Abstract][Full Text] [Related]
19. Strain differences in the response of Fischer 344 and Sprague-Dawley rats to monocrotaline induced pulmonary vascular disease.
Pan LC; Wilson DW; Segall HJ
Toxicology; 1993 Mar; 79(1):21-35. PubMed ID: 8475497
[TBL] [Abstract][Full Text] [Related]
20. Effects of monocrotaline pyrrole on cultured rat pulmonary endothelium.
Hoorn CM; Wagner JG; Roth RA
Toxicol Appl Pharmacol; 1993 Jun; 120(2):281-7. PubMed ID: 8511798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
